Pulmonary hypertension in a child with juvenile myelomonocytic leukemia secondary to pulmonary leukemic cell infiltration

Pediatric Hematology and Oncology

Volumn 23, Issue 8, 2006, Pages 667-675

  Alioglu, Bulent ^a   Demirhan, Beyhan ^a   Ozyurek, Emel ^a   Varan, Birgul ^a   Erbay, Ayse ^b   Ozbek, Namik ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Dr Behcet Uz Childrens Public Hospital   (Turkey)

Author keywords

Juvenile myelomonocytic leukemia; Myelodysplastic syndrome; Pulmonary hypertension; Pulmonary leukemic cell infiltration

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CEFEPIME; COTRIMOXAZOLE; HYDROXYUREA; VANCOMYCIN;

ARTICLE; ASSISTED VENTILATION; AUTOPSY; CANCER INVASION; CARDIOMEGALY; CASE REPORT; CELL INFILTRATION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HUMAN CELL; HUMAN TISSUE; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKEMIA CELL; LUNG BIOPSY; MICROBIOLOGICAL EXAMINATION; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PULMONARY HYPERTENSION; PULMONARY VALVE STENOSIS; RADIODIAGNOSIS; THORAX RADIOGRAPHY; TRICUSPID VALVE REGURGITATION;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DIAGNOSTIC ERRORS; FATAL OUTCOME; FEMALE; HUMANS; HYDROXYUREA; HYPERTENSION, PULMONARY; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LEUKEMIC INFILTRATION; LUNG; RESPIRATION, ARTIFICIAL; SEPSIS; TRICUSPID VALVE INSUFFICIENCY;

EID: 33750451642     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010600962127     Document Type: Article

References (26)

1. Arico M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia: review article. Blood. 1997;90:479-488.
2. Emanuel PD. Juvenile myelomonocytic leukemia. Curr Hematol Rep. 2004;3:203-209.
3. Fineman SL, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1993:459-466.
4. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111-117.
5. Vazquez de Prada JA, Ruano J, Martin-Duran R, et al. Noninvasive determination of pulmonary arterial systolic pressure by continuous wave Doppler. Int J Cardiol. 1987;16:177-184.
6. Archer S, Rich S. Primary pulmonary hypertension: a vascular biology and translational research "work in progress." Circulation. 2000;102:2781-2791.
7. Ewig S, Glasmacher A, Ulrich B, Wilhelm K, Schafer H, Nachhtseim KH. Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors. Chest. 1998;114:444-451.
8. Niemeyer CM, Arico M, Basso G, et al. members of the European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood. 1997;89:3534-3543.
9. Cetin M, Tunc B, Tuncer AM, Gumruk F, Yenicesu I. Dramatic resolution of pleural effusion in children with chronic myelomonocytic leukemia following short-course high-dose methylprednisolone. Leuk Lymphoma. 1998;29:617-623.
10. Azoulay E, Fieux F, Moreau D, et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med. 2003;167:1329-1333.
11. Rossoff LJ, Genovesc J, Coleman M, Dantzker DR. Primary pulmonary hypertension in a patient with CD8/T-cell large granulocyte leukemia: amelioration by cladribine therapy. Chest. 1997;112:551-553.
12. Vaksmann G, Nelken B, Deshildre A, Rey C. Pulmonary arterial occlusive disease following chemotherapy and bone marrow transplantation for leukaemia. Eur J Pediatr. 2002;161:247-249.
13. Bentur L, Cullinane C, Wilson P, Greenberg M, O'Brodovich H, Silver MM. Fatal pulmonary arterial occlusive vascular disease following chemotherapy in a 9-month-old infant. Hum Pathol. 1991;22:1295-1298.
14. Fruehauf S, Steiger S, Topaly J, Ho AD. Pulmonary artery hypertension during interferon-a therapy for chronic myelogenous leukemia. Ann Hematol. 2001;80:308-310.
15. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest. 2001;120:801-808.
16. Azoulay E, Eddahibi S, Marcos E, et al. Granulocyte colony-stimulating factor enhances alpha-naphthylthiourea-induced pulmonary hypertension. J Appl Physiol. 2003;94:2027-2033.
17. Fujita M, Mason RJ, Cool C, Shannon JM, Hara N, Fagan KA. Pulmonary hypertension in TNF-α-overexpressing mice is associated with decreased VEGF gene expression. J Appl Physiol. 2002;93:2162-2170.
18. Itoh A, Nishihira J, Makita H, Miyamoto K, Yamaguchie E, Nishimura M. Effects of IL-1β, TNF-α, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells. Respirology. 2003;8:467-472.
19. Lymphoproliferative disorders, myelodysplastic syndromes, and myeloproliferative disorders. In: Lanzkowsky P, ed. Manual of Pediatric Hematology and Oncology, 4th ed. Burlington, MA: Elsevier; 2005;397-401.
20. Seguchi M, Hirabayashi N, Fujii Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation. 2000;69:177-179.
21. Manero GC, Schuster SJ, Patrick H, Martinez J. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol. 1999;60:130-135.
22. Murin S. Pulmonary hypertension and leukemia. Chest. 1998;113:851-852.
23. Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med. 2005;33:2488-2493.
24. Dombret H, Hunault M, Faucher C, Dombret MC, Degos L. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer. 1992;69:1356-1361.
25. Marvin KS, Spellberg RD. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia. Chest. 1993;103:642-644.
26. Rostagno C, Prisco D, Abbate R, Poggesi L. Pulmonary hypertension associated with long-standing thrombocytosis. Chest. 1991;99:1303-1305.